ICU Medical Q2 revenue beat estimates on strength in Infusion Systems - ICUI News | Rallies
ICU Medical Q2 revenue beat estimates on strength in Infusion Systems I ICUI • 2026-08-06 Outlook
Company raises FY 2026 GAAP net income forecast to $73 mln-$83 mln from $26 mln-$44 mln
Company raises FY 2026 GAAP diluted EPS forecast to $2.89-$3.29 from $1.03-$1.74
Company raises FY 2026 adjusted EBITDA forecast to $415 mln-$435 mln from $400 mln-$430 mln
Company raises FY 2026 adjusted diluted EPS forecast to $8.60-$9.00 from $7.75-$8.45
Overview
U.S. medical device maker's Q2 revenue grew 1%, beating analyst expectations
Adjusted EPS and adjusted EBITDA for Q2 beat analyst expectations
Company raised full-year 2026 guidance for GAAP and adjusted EPS and adjusted EBITDA
Key details Metric Beat/Miss Actual Consensus Estimate Q2 Revenue Beat $551.68 mln $533.43 mln (7 Analysts) Q2 Adjusted EPS Beat $2.37 $1.91 (7 Analysts) Q2 Gross Margin 43.00% Q2 Gross Profit $235.05 mln
Result drivers
Infusion Systems growth - Co said Infusion Systems results were ahead of expectations, contributing to overall revenue growth
Divestiture impact - Year-over-year comparisons reflect the strategic divestiture of the IV Solutions business in May 2025, affecting Vital Care revenue
Gross margin improvement - Gross margin rose to 43% from 38% a year earlier; co did not specify exact drivers for the increase•
2026-08-06
ICUI•
